semaglutide .25 Wegovy (semaglutide) Injector 0.25 mg/0.5 mL (4-Pack) — Mountainside Medical Semalix 0.25 mg/0.5 mg Pre-filled
Description
During Wegovy clinical trials, close to 44% of Wegovy users experienced nausea and nearly 25% of the test subjects also reported incidents of vomiting

Friedman, bilogo molecular, (Estados Unidos)
26, supl

The Evolving Landscape of Anti-Obesity Drugs The field of anti-obesity drug development is rapidly evolving, with new therapies emerging that offer the potential for more effective and personalised weight management
